Our findings suggest that reduced AURKA activity in AD could contribute to developing intraneuronal accumulation of Aβ and extracellular amyloid plaque formation and that activating AURKA may represent a therapeutic strategy against AD. Here, AURKA is linked to Alzheimer disease.